Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLID.L Regulatory News (LID)

  • There is currently no data for LID

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 (OPD) - LiDCO Group Plc

6 Nov 2020 07:00

RNS Number : 4423E
LiDCO Group Plc
06 November 2020
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

LiDCO Group plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

LiDCO Group plc

(d) Is the discloser the offeror or the offeree?

OFFEREE

(e) Date position held:

The latest practicable date prior to the disclosure

30 October 2020

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

 N/A

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

Ordinary shares of 0.5p in LiDCO Group plc

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

Nil

Nil

Nil

(2) Cash-settled derivatives:

 

Nil

Nil

Nil

Nil

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

Nil

Nil

Nil

 

TOTAL:

Nil

Nil

Nil

Nil

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

(A) Interests held by the directors of LiDCO Group plc and their close relatives and related trusts:

 

Director

No. of ordinary shares of 0.5p each held

Percentage of issued share capital

Peter Grant

944,163

0.39%

Matthew Sassone

250,000

0.10%

Tim Hall

100,000

0.04%

Philip Cooper

2,666,667

1.09%

James Wetrich

19,900

0.01%

 

 

(B) Interests held as options or awards by directors of LiDCO Group plc granted under the LiDCO Group plc Share Option Plan 2013 (the "Share Option Plan") which have vested but where the director has not exercised their right to acquire or receive the shares:

 

Director

Scheme

Original no. of ordinary shares of 0.5p each under option / award (1)

Exercise price

Vesting date

Last date for exercise (2)

Percentage of issued share capital (3)

Matt Sassone

Share Option Plan

1,248,262

0.5 pence per share

15 June 2018

15 June 2025

0.51%

949,540

0.5 pence per share

15 June 2018

15 June 2025

0.39%

2,197,802

0.5 pence per share

15 June 2019

15 June 2025

0.90%

2,200,000

0.5 pence per share

11 April 2020

10 April 2022

0.90%

 

(1) The number shown in this column is the maximum number of ordinary shares which are capable of being acquired in connection with that option. The actual number of shares which may be acquired may be less, depending on performance against a share price performance condition.

(2) The date shown in this column is the last date on which the option may be exercised, but for any earlier change of control of the Offeree in which case the last date for exercise shall be the date 90 days after the date of the change of control. Subject to it becoming unconditional in all respects, the Offer will constitute such a change of control.

(3) The percentage stated is calculated relative to the undiluted share capital of LiDCO Group plc of 244,174,908 ordinary shares.

 

 

(C) Interests held as options or awards by directors of LiDCO Group plc granted under the Share Option Plan which have not yet vested:

 

 

Director

Scheme

No. of ordinary shares of 0.5p each under option / award (3)

Exercise price

Vesting date

Last date for exercise (4)

Percentage of issued share capital (5)

Matthew Sassone

Share Option Plan

1,000,000

0.5 pence per share

20 April 2021

 

19 April 2023

0.41%

2,000,000

0.5 pence per share

9 April 2022

8 April 2024

0.82%

Tim Hall

Share Option Plan

2,000,000

0.5 pence per share

9 April 2022

8 April 2024

0.82%

1,000,000

0.5 pence per share

29 April 2023

28 April 2025

0.41%

1,000,000

0.5 pence per share

29 April 2024

28 April 2026

0.41%

 

(3) The number shown in this column is the maximum number of ordinary shares which are capable of being acquired in connection with that option. The actual number of shares which may be acquired may be less, depending on performance against a share price performance condition.

 

(4) The date shown in this column is the last date on which the option may be exercised, but for any earlier change of control of the Offeree in which case the last date for exercise shall be the date 90 days after the date of the change of control. Subject to it becoming unconditional in all respects, the Offer will constitute such a change of control.

 

(5) The percentage stated is calculated relative to the undiluted share capital of LiDCO Group plc of 244,174,908 ordinary shares.

 

 

(D) Interests of connected advisers of LiDCO Group plc

 

Class of relevant security

Ordinary shares of 0.5p each in LiDCO Group plc

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled

Nil

Nil

Nil

Nil

(2) Cash-settled derivatives

Nil

Nil

Nil

Nil

(3) Stock-settled derivatives

Nil

Nil

Nil

Nil

 

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

 

None

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

6th November 2020

Contact name:

Tim Hall

Telephone number:

020 7749 1509

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEEDELFBBFLLFBD
Date   Source Headline
26th Jun 201212:40 pmRNSNotification of Major Interest in Shares
26th Jun 201212:40 pmRNSNotification of Major Interest in Shares
22nd Jun 20123:05 pmRNSExercise of Share Options
13th Jun 201211:55 amRNSResult of AGM
13th Jun 20127:00 amRNSLaunch of the LiDCOrapid monitor in Japan
12th Jun 20127:00 amRNSAnnual Report and Accounts and Notice of AGM
29th May 20127:00 amRNSLiDCOrapid Registration in Japan
10th May 20127:00 amRNSLiDCO technologies highlighted in NHS report
4th May 20127:00 amRNSExercise of Share Options
25th Apr 201210:40 amRNSGrant of share option
24th Apr 20127:00 amRNSPreliminary Results
28th Mar 20123:10 pmRNSExercise of Share Option
23rd Feb 20127:00 amRNSTrading Update and Notice of Results and AGM
8th Feb 20124:31 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
9th Jan 20127:00 amRNSLiDCO signs licensing agreement with CNSystems
12th Dec 20112:30 pmRNSExercise of a Share Option
7th Dec 20117:00 amRNSNHS Innovation Review
26th Oct 20117:00 amRNSInterim Results
12th Oct 20117:00 amRNSLiDCO monitor reduces surgical complications
24th Aug 201111:42 amRNSDirector/PDMR Shareholding
23rd Aug 20117:00 amRNSPre- close trading update
29th Jul 20117:00 amRNSExercise of Share Options
28th Jul 20117:00 amRNSNotice of Results
20th Jul 20113:25 pmRNSDirector's Holdings
14th Jul 20114:22 pmRNSExercise of a Share Option / Director's Holdings
14th Jul 20117:00 amRNSLiDCO signs agreement with ICU Medical, Inc
29th Jun 201111:45 amRNSResult of AGM
29th Jun 20117:00 amRNSJapanese Registration and Supply Agreement
1st Jun 20112:00 pmRNSPosting of Annual Report and Notice of AGM
17th May 20117:00 amRNSIssue of Equity
21st Apr 201111:45 amRNSDirector/PDMR Shareholding
20th Apr 20114:20 pmRNSDirector/PDMR Shareholding
19th Apr 20117:00 amRNSGrant of Share Options
18th Apr 20117:00 amRNSPreliminary Results
18th Apr 20117:00 amRNSDirectorate Change
15th Apr 201111:45 amRNSHolding(s) in Company
21st Mar 20117:00 amRNSDistribution Contract
24th Feb 20117:00 amRNSTrading Update and Notice of Results and AGM
26th Oct 20107:00 amRNSInterim Results
26th Oct 20107:00 amRNSInterim Results
15th Oct 20107:00 amRNSLiDCO monitors link with GE Healthcare
23rd Aug 20107:00 amRNSIssue of Equity
17th Aug 20102:50 pmRNSPre-Close Trading Update
12th Aug 20107:00 amRNSNotice of Results
12th Jul 20109:00 amRNSDirector's Share Transaction
2nd Jul 20107:00 amRNSLiDCO study day receives RCN accreditation
29th Jun 201011:40 amRNSResult of AGM
7th Jun 20101:30 pmRNS2010 Annual Report and Accounts & Notice of AGM
4th Jun 20107:00 amRNSDirectors dealings and grant of options
10th May 20107:00 amRNSMultiparameter monitoring reduces risk in surgery

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.